Ultralife Corporation (ULBI)
NASDAQ: ULBI
· Real-Time Price · USD
8.17
0.43 (5.56%)
At close: Jun 16, 2025, 3:59 PM
7.88
-3.55%
Pre-market: Jun 17, 2025, 08:00 AM EDT
Ultralife Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|
| Battery & Energy Products Segment Revenue | 129.95M | 120M | 87.08M | 29M | 23.87M |
| Battery & Energy Products Segment Revenue Growth | +8.30% | +37.79% | +200.30% | +21.50% | n/a |
| Communications Systems Segment Revenue | 28.69M | 11.85M | 11.18M | 15.74M | 17.71M |
| Communications Systems Segment Revenue Growth | +142.22% | +5.91% | -28.95% | -11.10% | n/a |
| Corporate Segment Revenue | n/a | n/a | n/a | n/a | n/a |
| Corporate Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|
| Non-Us Revenue | 67.42M | 77.25M | 63.93M | 1.52M | 2.2M |
| Non-Us Revenue Growth | -12.73% | +20.84% | +4091.87% | -30.68% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Dec 31, 2016 | Sep 25, 2016 | Jun 26, 2016 | Mar 27, 2016 | Dec 31, 2015 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.94M | 6.71M | 6.07M | 5.65M | 5.45M | 5.9M | 5.77M | 5.14M | 5.38M | 6.21M | 5.41M | 5.18M | 5.4M | 4.92M | 4.16M | 4.32M | 4.38M | 4.62M | 4.2M | 4.39M | 4.3M | 4.73M | 4.53M | 4.24M | 3.5M | 3.55M | 3.38M | 3.64M | 3.76M | 3.76M | 3.57M | 3.65M | 3.85M | 3.65M | 3.42M | 3.89M | 4.18M | 3.2M | 3.47M | 3.68M | 3.8M |
| Selling, General, and Administrative Revenue Growth | +3.44% | +10.56% | +7.45% | +3.69% | -7.68% | +2.27% | +12.15% | -4.33% | -13.37% | +14.86% | +4.32% | -3.98% | +9.79% | +18.04% | -3.68% | -1.28% | -5.18% | +10.00% | -4.46% | +2.16% | -9.07% | +4.51% | +6.85% | +21.03% | -1.44% | +5.03% | -7.01% | -3.32% | +0.11% | +5.15% | -2.14% | -5.07% | +5.28% | +6.75% | -12.05% | -6.94% | +30.82% | -8.00% | -5.65% | -3.05% | n/a |
| Research and Development Revenue | 2.4M | 2.41M | 2.1M | 2M | 1.73M | 1.85M | 1.87M | 1.78M | 2.03M | 1.66M | 1.9M | 1.67M | 1.86M | 1.6M | 1.72M | 1.85M | 1.65M | 1.52M | 1.61M | 1.27M | 1.55M | 2.15M | 2.03M | 1.59M | 1.04M | 1.09M | 1.1M | 1.22M | 1.1M | 1.06M | 1.35M | 1.19M | 1.14M | 1.51M | 1.36M | 1.43M | 1.66M | 1.69M | 1.22M | 1.33M | 1.36M |
| Research and Development Revenue Growth | -0.41% | +14.90% | +5.21% | +15.37% | -6.53% | -0.91% | +5.12% | -12.50% | +22.71% | -12.66% | +13.40% | -9.96% | +15.85% | -6.96% | -7.02% | +12.51% | +8.50% | -5.48% | +25.96% | -17.64% | -28.10% | +6.11% | +27.85% | +53.19% | -5.13% | -0.64% | -9.77% | +10.63% | +3.97% | -21.85% | +14.35% | +4.13% | -24.54% | +11.13% | -4.77% | -13.95% | -1.78% | +37.75% | -8.25% | -1.84% | n/a |